When people think about joint health, they think about cartilage. The smooth, pearlescent tissue that cushions bone ends gets most of the attention in discussions of osteoarthritis, joint pain, and supplementation. What almost never gets mentioned is the structure directly beneath that cartilage – a dense layer of specialised bone called subchondral bone that is, in many respects, just as important to what happens inside a joint as the cartilage sitting on top of it.
Understanding subchondral bone does not require a medical degree, but it does require looking slightly deeper than the standard joint health conversation goes. What follows is that deeper look – what subchondral bone is, what it does, what happens to it in joint disease, and why it matters for anyone trying to protect or manage their joint health intelligently.
Contents
The Anatomy: Where Subchondral Bone Sits and What It Consists Of
The word subchondral comes from the Latin for “under cartilage,” which describes its location precisely. In a synovial joint – the knee, hip, shoulder, and similar joints – articular cartilage covers the ends of the bones where they meet. Directly beneath this cartilage, before you reach the spongy interior bone tissue, is the subchondral bone: a dense, calcified layer that forms the foundation on which cartilage sits and from which it derives part of its structural support.
Subchondral bone is not a single uniform structure. It consists of two distinct zones. The subchondral bone plate is the thin, densely mineralised layer immediately adjacent to cartilage, providing a firm platform for cartilage’s load-bearing function. Beneath that plate is the subchondral trabecular bone, a network of bony struts arranged in a pattern that distributes compressive forces throughout the bone in the most mechanically efficient way possible. Together, these two zones form what researchers increasingly refer to as the osteochondral unit – a term that acknowledges that cartilage and subchondral bone function as an integrated system rather than as independent tissues that happen to sit next to each other.
What Subchondral Bone Actually Does
The primary function of subchondral bone is mechanical: it acts as a secondary shock absorber beneath the primary shock absorber of cartilage. When compressive forces pass through a joint – during walking, stair climbing, running, or any weight-bearing activity – cartilage handles the initial load distribution, but subchondral bone provides the structural platform that makes that load distribution possible and absorbs the forces that pass through cartilage to the bone below.
Healthy subchondral bone is not rigid like cortical bone. It has a degree of elasticity that allows it to deform slightly under load and spring back, a property that dissipates energy and reduces peak stresses at the cartilage-bone interface. This controlled deformation and recovery is partly why the trabecular architecture of subchondral bone matters: the angle and spacing of the bony struts in the trabecular network are optimised for the specific loading patterns of each joint, which is why the subchondral bone architecture in the knee looks different from that of the hip or the shoulder.
Subchondral bone also plays a role in cartilage nutrition that is only recently being fully appreciated. Although cartilage is avascular and depends primarily on synovial fluid for nutrient delivery, there is a degree of molecular exchange across the cartilage-bone interface, particularly in areas where the calcified cartilage layer transitions to the subchondral bone plate. The vascular supply of subchondral bone contributes small-molecule nutrients to the deepest zones of cartilage through this diffusion pathway, making subchondral bone health a contributor to cartilage nutrition alongside the better-known synovial fluid mechanism.
What Goes Wrong: Subchondral Bone Changes in Osteoarthritis
The relationship between subchondral bone changes and osteoarthritis has shifted dramatically in research understanding over the past two decades. The old model treated subchondral bone changes as a downstream consequence of cartilage loss: once cartilage wore away and bone-on-bone contact occurred, the exposed bone responded by changing its structure. The current understanding is considerably more nuanced and more troubling.
Subchondral Bone Changes Precede Cartilage Loss
Research using sensitive imaging technologies has demonstrated that subchondral bone changes can be detected before significant cartilage loss is apparent. In the early stages of osteoarthritis development, the subchondral bone plate may begin to thicken, the trabecular architecture may change its pattern, and the vascularity of the subchondral region may increase as the bone attempts to adapt to altered loading conditions. These changes alter the mechanical environment that cartilage experiences, potentially accelerating the cartilage deterioration that was previously assumed to be the primary event. The relationship, in other words, is bidirectional: damaged cartilage affects subchondral bone, but altered subchondral bone also damages cartilage.
Sclerosis: When Adaptive Thickening Becomes Counterproductive
In response to increased loading – from cartilage loss, altered biomechanics, or both – the subchondral bone plate often becomes thicker and denser, a process called subchondral sclerosis. This thickening is an adaptive response, the bone’s attempt to handle forces that the overlying cartilage can no longer manage effectively. The problem is that a stiffer, sclerotic subchondral bone loses the elasticity that allowed it to dissipate impact forces. It transmits more of the compressive load back to cartilage rather than absorbing it, creating a mechanical environment that accelerates the very cartilage deterioration that triggered the sclerosis in the first place. Subchondral sclerosis is visible on standard X-rays as increased whiteness or density beneath the joint surface, and its presence is one of the radiological markers of established osteoarthritis.
Bone Marrow Lesions and Joint Pain
MRI scanning has revealed another feature of subchondral bone pathology that is invisible on X-ray: bone marrow lesions, sometimes called bone marrow edema lesions, which appear as areas of increased fluid signal within the subchondral bone on MRI. These lesions likely represent areas of microdamage, localised ischemia, or trabecular damage within the subchondral region. Their clinical significance is considerable: the size and number of bone marrow lesions in osteoarthritic joints correlates strongly with both pain severity and the rate of subsequent cartilage loss. This has led researchers to propose that subchondral bone marrow lesions are not merely a marker of joint disease but an active contributor to both the pain experience and the structural progression of osteoarthritis.
Why This Matters for Joint Health Decisions
The subchondral bone story has several practical implications for how to think about joint health management, including supplementation choices. First, it reinforces the importance of preserving cartilage before significant loss occurs, because once subchondral sclerosis is established, the mechanical environment in the joint becomes increasingly hostile to cartilage survival regardless of structural support provided nutritionally. The case for early intervention with ingredients like Glucosamine Sulfate 2KCL and Phytodroitin™ – which support the cartilage matrix from which subchondral changes partly arise – is strengthened by understanding that cartilage loss and subchondral bone deterioration are a mutually reinforcing cycle best interrupted early.
Second, it helps explain why bone-targeted supplements like calcium and vitamin D are not adequate substitutes for joint-specific supplementation. Subchondral bone health is not simply a matter of bone mineral density – it involves the architectural properties, the vascular supply, and the mechanical responsiveness of a specialised bone tissue whose behaviour is shaped by joint loading mechanics and the inflammatory environment of the joint as much as by mineral content. For more on how vitamin D specifically influences both bone and joint tissue, our article on vitamin D and K2 in bone and joint health covers the relevant mechanisms.
Third, the bone marrow lesion findings highlight why managing joint inflammation is relevant not only to pain control but to structural joint health. The inflammatory environment of an osteoarthritic joint appears to influence subchondral bone biology in ways that contribute to bone marrow lesion formation, suggesting that anti-inflammatory management through ingredients like CurcuWIN® and AprèsFlex® is addressing a structural dimension as well as a symptomatic one.
Frequently Asked Questions
- Can subchondral bone changes be reversed?
- Early subchondral bone changes, including some bone marrow lesions, have been shown to partially resolve with interventions that reduce joint loading – most notably significant weight loss and activity modification that reduces peak joint forces. Established subchondral sclerosis is less reversible, as it represents structural remodelling of the bone architecture. The window for meaningful intervention appears to be the period before significant sclerosis has developed, reinforcing the value of early joint health management.
- Is subchondral bone the same as cortical bone?
- No, though the subchondral bone plate has some structural similarities to cortical bone in its density. Cortical bone forms the hard outer shell of long bones generally. Subchondral bone is a specialised zone at the articular surface of joint bones, with specific architectural and mechanical properties adapted to the demands of joint loading. The trabecular component of subchondral bone is distinctly different from cortical bone in its porous, strut-based organisation.
- Do standard bone density scans (DEXA) assess subchondral bone health?
- DEXA scans measure bone mineral density across broad skeletal regions and are designed to assess osteoporosis risk rather than subchondral bone quality or architecture. They cannot detect the trabecular architectural changes, bone marrow lesions, or localised sclerosis patterns that characterise subchondral bone pathology in osteoarthritis. MRI is the most sensitive imaging modality for subchondral bone pathology relevant to joint health, while standard X-rays can detect established sclerosis but miss early changes.
Subchondral bone is the foundation on which cartilage health is built, and like any foundation, its condition determines what can be sustained above it. The growing recognition in rheumatology research that osteoarthritis is a whole-joint disease rather than a cartilage-only disease reflects exactly this understanding. For the broader picture of what joints are made of and how their components interact, our article on what joints are actually made of provides the anatomical context that makes the subchondral bone story easier to place.
